Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Sridhar Vasudevan (Department of Pharmacology) received Medical Research Council Confidence in Concept funding to investigate a series of drugs which could be used to modulate and treat circadian rhythm disorders. He discusses his research, and how this funding enabled him to accelerate his successes.

 Interview transcript 

Project overview

Circadian rhythms regulate the most basic physiological processes. In humans, circadian rhythm disruption can lead to a variety of health problems. This project investigated drug candidates for treating this disruption, allowing the researchers to collect more data about which drug would be most effective. 

Researcher profile

Sridhar VasudevanDr Sridhar Vasudevan 

Research Fellow and Departmental Lecturer

Department of Pharmacology



This project received £46k from the Medical Research Council Confidence in Concept fund between October 2015 and July 2016.The panel noted the challenges of repurposing drugs but following feedback from the MRC Developmental Pathway Funding Scheme panel, MRC CiC funding was awarded to support the project in obtaining further pilot data. 

Related links

Department of Pharmacology

Vasudevan Group

Circadian Therapeutics